Newsletter Subscribe
Enter your email address below and subscribe to our newsletter
Patient Education
Share your love
Opus Genetics doses first patient in LYNX-3, phase 3 trial of phentolamine ophthalmic solution 0.75%
(Image Credit: AdobeStock/svetlanais) Opus Genetics has dosed the first patient in LYNX-3, its pivotal phase 3 clinical trial of phentolamine ophthalmic solution 0.75% in treating significant, chronic night driving impairment in keratorefractive patients with reduced mesopic vision. Night-vision disturbances, which…
Hispanic patients with POAG had lower success rates after glaucoma surgery compared with patients of European descent
(Image credit: AdobeStock/Vladislav) A study reported lower success rates associated with initial trabeculectomy with mitomycin C (MMC) in Hispanic patients compared with those who were of European descent. This information may be useful when considering patient candidacy for glaucoma surgery,1…
Glaucoma-focused session with Angelo P. Tanna, MD, launches Northwestern University’s “Dinner with the Experts” series
Kicking off Northwestern University’s “Dinner with the Experts” series, Angelo P. Tanna, MD, leads a deep dive into OCT and perimetry for glaucoma progression on September 9, 2025. (Image credit: AdobeStock/FourLeafLover) As part of its new “Dinner with the Experts…
Inside Northwestern University’s “Dinner with the Experts” educational series with Robert S. Feder, MD
The Northwestern University Department of Ophthalmology is launching “Dinner with the Experts – Cases, Updates, and Clinical Pearls,” a collaborative space for sharing ophthalmic knowledge and practical takeaways. (Image credit: AdobeStock/Harsha) The Northwestern University Department of Ophthalmology is launching a…
Creation of OpZira Inc. announced following Alcon’s acquisition of LumiThera
(Image credit: AdobeStock) The company OpZira Inc. has launched to advance ophthalmic diagnostics. The company plans to deliver innovative technologies with the ability to enhance the detection and monitoring of ocular disease, which can empower clinicians. Clark Tedford, PhD, President…
VirtuaLens launches virtual reality tool: Immersive IOL Simulator
(Image credit: AdobeStock/DeepView) VirtuaLens has launched its Immersive IOL Simulator. This is a virtual reality (VR) platform that is designed to allow cataract patients to explore and compare different intraocular lens (IOL) options before surgery. The company notes that the…
Sight Science’s TearCare System earns spot in TFOS DEWS III dry eye report
(Image Credit: AdobeStock/tadamichi) Sight Sciences announced that its TearCare System has been included in the new Dry Eye Workshop (DEWS) III report from the Tear Film and Ocular Surface Society (TFOS) published in the American Journal of Ophthalmology.1,2 This marks the…
Ophthalmic Devices Market Surges to USD 100.2 Billion by 2033, Propelled by 6.4% CAGR
\n \n The Ophthalmic Devices Market is witnessing robust expansion driven by rising demand for advanced eye care solutions, growing prevalence of vision disorders, and a rapidly aging population. Technological advancements such as AI-driven diagnostics, minimally invasive surgical systems, and…
Treating ophthalmic artery stenosis in geographic atrophy with angioplasty
(Image credit: AdobeStock/Rina) A study that evaluated the safety and feasibility of treating ophthalmic artery stenoses with angioplasty in patients with late-stage age-related macular degeneration (AMD) with geographic atrophy (GA) showed reported observing efficacy and functional improvement in this patient…
The state of retina at ASRS 2025 with Charles C. Wykoff, MD, PhD, and Kevin Quinn
(Image credit: AdobeStock/vetrana) The annual scientific meeting of the American Society of Retina Specialists (ASRS) was held in Long Beach, California from July 30 through August 2, 2025. At this event, researchers and experts in the retina field shared data…